Smoking cessation aids

Komal Roopchandani, Indrajeet Singhvi, Mousumi Kar

Abstract


Smoking is a practice where a substance, most commonly tobacco as dried or curled leaves is burned and the smoke is tasted or inhaled. This is primarily done as a recreational activity. But, owing to the chemicals present in tobacco, it
slowly becomes addictive in nature. Few smokers use effective smoking cessation aids when trying to stop smoking. Smoking is the most important single cause of morbidity and mortality in under developed, developing and developed countries.
Because smoking prevention will not affect tobacco-related mortality, quitting by current smokers is the main way to achieve positive effects on mortality. Many smokers are interested in quitting. Most of the smokers try to quit smoking at
least once in their lifetime. To support smokers in their quit attempts, a wide range of smoking cessation aids is available. These comprise methods and products to assist smokers in quitting through coping with psychological or physical aspects of nicotine dependence. Meta-analyses have shown that smoking cessation courses, nicotine replacement therapy, and bupropion
can significantly increase success rates in quitting. Even minimal interventions such as self-help materials have a small effect
when compared with no intervention.


Full Text:

PDF

References


American Cancer Society. Cancer Facts and Figures 2006. Atlanta, Ga:

American Cancer Society. Cancer Prevention and Early Detection Facts

and Figures 2005. Atlanta, Ga: 2005.

Agency for Health Care Policy and Research, Clinical Practice Guideline

on Smoking Cessation, No. 18, AHCPR, Rockville, MD: April 1997.

American Lung Association. Trends in Tobacco Use, January 2006.

CDC National Center for Chronic Disease Prevention and Health

Promotion. Quit to Live: How and Why to Quit Smoking Today.

Centers for Disease Control and Prevention (CDC). Annual smoking-

attributable mortality, years of potential life lost, and economic

costs - United States, 1995-1999. MMWR Morb Mortal Wkly Rep

;51:300-3.

Centers for Disease Control. Best practices for comprehensive tobacco

control programs – August 1999. Atlanta, GA: US Department of Health

and Human Services, Public Health Service, CDC, National Center for

Chronic Disease Prevention and Health Promotion, Office on Smoking

and Health, 1999.

Centers for Disease Control. Cigarette Smoking Adults – United States,

Morbidity and Mortality Weekly Report. Atlanta, GA. Centers for

Disease Control and Prevention.

Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of

the nicotine patch for smoking cessation: A meta-analysis. JAMA

;271:1940-7.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A

comparison of sustained-release bupropion and placebo for smoking

cessation. N Engl J Med 1997;337:1195-202.

Joad JP. Smoking and pediatric respiratory health. Clin Chest Med

;21:37-46.

Joseph AM, Fu SS. Safety issues in pharmacotherapy for smoking

in patients with cardiovascular disease. Progr Cardiovasc Dis

;45:429-41.

Joseph AM, Fu SS. Smoking cessation for patients with cardiovascular

disease: What is the best approach? Am J Cardiovasc Drugs

;3:339-49.

Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, et

al. Efficacy and safety of the novel selective nicotinic acetylcholine

receptor partial agonist, varenicline, for smoking cessation. Arch Intern

Med 2006;166:1571-7.

Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse

pressure amplication. Hypertension 2003;41:183-7.

Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, et al.Smoking cessation with varenicline, a selective alpha4beta2 nicotinic

receptor partial agonist: Results from a 7-week, randomized, placebo-

and bupropion-controlled trial with 1-year follow-up. Arch Intern Med

;166:1561-8.

Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking- cessation and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. BMJ 2000;321:323-9.

Schroeder SA. What to do with a patient who smokes: Grand Rounds at

the University of California, San Francisco. JAMA 2005;294:482-7.

Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, Shadel WG.

Reduction of abstinence-induced withdrawal and craving using high-dose

nicotine replacement therapy. Psychopharmacology 2006;184:637-44.

Shiffman S, Scharf DM, Shadel WG, Gwaltney CJ, Dang Q, Paton SM, et al. Analyzing milestones in smoking cessation: Illustration in a nicotine

patch trial in adult smokers. J Consult Clin Psychol 2006;74:276-85.

Stapleton JA, Russell MA, Feyerabend C, Wiseman SM, Gustavsson G,

Sawe U, et al. Dose effects and predictors of outcome in a randomized

trial of transdermal nicotine patches in general practice. Addiction

;90:31-42.

Tonnesen P, Norregaard J, Simonsen K, Säwe U. A double-blind trial of

a 16-hour transdermal nicotine patch in smoking cessation. N Engl J

Med 1991;325:311-5.

Tønnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer

H, et al. Two and four mg nicotine chewing gum and group counseling

in smoking cessation: An open, randomized, controlled trial with a 22

month follow-up. Addict Behav 1988;13:17-27.

Transdermal Nicotine Study Group. Transdermal nicotine for smoking

cessation: Six-month results from two multicenter controlled clinical

trials. JAMA 1991;266:3133-8.

Underner M, Paquereau J, Meurice JC. Cigarette smoking and sleep

disturbances. Rev Mal Respir 2006;23:67.

US Department of Health and Human Services. The Health Benefits of

Smoking Cessation: A Report of the Surgeon General. Centers for Disease

Control and Prevention (CDC), Office on Smoking and Health. 1990.

US Department of Health and Human Ser vices. The Health

Consequences of Smoking: A Report of the Surgeon General. Centers

for Disease Control and Prevention (CDC), Office on Smoking and

Health. 2004.

US Department of Health and Human Ser vices. The Health

Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon

General. Centers for Disease Control and Prevention (CDC), Office on

Smoking and Health. 1988.

US Department of Health and Human Services. Reducing the Health

Consequences of Smoking: 25 years of Progress. A Report of the

Surgeon General. Centers for Disease Control and Prevention (CDC),

Office on Smoking and Health. 1989.

US Department of Health and Human Services. Reducing Tobacco Use:

A Report of the Surgeon General. Centers for Disease Control and

Prevention (CDC), Office on Smoking and Health. 2000.

White AR, Rampes H, Ernst E. Acupuncture for smoking cessation.

Cochrane Database Syst Rev 2002;2.

White AR, Rampes H, Campbell JL. Acupuncture and related

interventions for smoking cessation. Cochrane Database Syst Rev

;(1):CD000009.

Zevin S, Jacob P 3rd, Benowitz NL. Dose-related cardiovascular and

endocrine effects of transdermal nicotine. Clin Pharmacol Ther

;64:87-95.

Nicotine Addiction in Britain. A report of the Royal College of Physicians,

February 2000.

Lader D, Goddard E. Smoking-related behaviour and attitudes, 2004.

London: ONS; 2005.

Smoking cessation guidelines and their cost effectiveness. Thorax

;53:S5 (part 2) S11.

Cigars: Health effects and trends. National Cancer Institute; 1998

Nicotine replacement therapy for smoking cessation. The Cochrane

Library, Issue 3, May 2001.

Bupropion to aid smoking cessation. Drug Ther Bull 2000;38:73-5.

Abstracts of the Cochrane review. The Cochrane Library, Issue 3,

West R. Getting serious about stopping smoking: A review of products,

services and techniques. 1997.

Statistics on NHS stop smoking services in England, April 2004 to

March 2005, NHS Health and Social Care Information Centre. Statistical

Bulletin 2005/03/HSCIC October 2005.

West R, Shiffman S. Smoking cessation. Fast Facts. Oxford: Health

Press; 2004.

American Cancer Society. Cancer Facts and Figures 2006. Atlanta, Ga:

American Cancer Society. Cancer Prevention and Early Detection Facts

and Figures 2005. Atlanta, Ga: 2005.

American Lung Association. Trends in Tobacco Use, January 2006.

CDC National Center for Chronic Disease Prevention and Health

Promotion. Quit to Live: How and Why to Quit Smoking Today.

Centers for Disease Control. Best practices for comprehensive tobacco

control programs – August 1999. Atlanta, GA: 18. US Department of

Health and Human public Health Service, CDC, National Center for

Chronic Disease Prevention and Health Promotion, Office on Smoking

and Health, 1999.

Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of

the nicotine patch for smoking cessation: A meta-analysis. JAMA

;271:1940-7.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA , Dale LC, et al. A

comparison of sustained-release bupropion and placebo for smoking

cessation. N Engl J Med 1997;337:1195-202.

Joad JP. Smoking and pediatric respiratory health. Clin Chest Med

;21:37-46,vii-viii.

Joseph AM, Fu SS. Safety issues in pharmacotherapy for smoking

in patients with cardiovascular disease. Prog Cardiovasc Dis

;45:429-41.

Joseph AM, Fu SS. Smoking cessation for patients with cardiovascular

disease: What is the best approach? AMJ Cardiovasc Drugs

;3:339-49.

Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, et

al. Efficacy and safety of the novel selective nicotinic acetylcholine

receptor partial agonist, varenicline, for smoking cessation. Arch Intern

Med 2006;166:1571-7.

Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse

pressure amplication. Hypertension 2003;441:183-7.

Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking

cessation and lung cancer in the UK since 1950: Combination of national

statistics with two case-control studies. BMJ 2000;321:323-9

Schroeder SA. What to do with a patient who smokes: Grand Rounds at

the University of California, San Francisco. JAMA 2005;294:482-7.

Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, Shadel WG.

Reduction of abstinence-induced withdrawal and craving using high-dose

nicotine replacement therapy. Psychopharmacology 2006;184:637-44.

Tonnesen P, Norregaard J, Simonsen K, Säwe U. A double-blind trial of

a 16-hour transdermal nicotine patch in smoking cessation. N Engl J

Med 1991;325:311-5.

Tønnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer

H, et al. Two and four mg nicotine chewing gum and group counseling

in controlled trial with a 22 month follow-up. Addict Behav

;13:17-27.

Transdermal Nicotine Study Group. Transdermal nicotine for smoking

cessation. Six-month results from two multicenter controlled clinical

trials. JAMA 1991;266:3133-8.

Underner M, Paquereau J, Meurice JC. Cigarette smoking and sleep

disturbances. Rev Mal Respir 2006;23:67.

US Department of Health and Human Ser vices. The Health

Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon

General. Centers for Disease Control and Prevention (CDC), Office on

Smoking and Health. 1988.

US Department of Health and Human Services. Reducing the Health

Consequences of Smoking: 25 years of Progress. A Report of the

Surgeon General. Centers for Disease Control and Prevention (CDC),

Office on Smoking and Health. 1989.

US Department of Health and Human Services. Reducing Tobacco Use:

A Report of the Surgeon General. Centers for Disease Control and

Prevention (CDC), Office on Smoking and Health, 2000.

White AR, Rampes H, Ernst E. Acupuncture for smoking cessation.

Cochrane Database Syst Rev 2002;(2):CD000009.

White AR, Rampes H, Campbell JL. Acupuncture and related

interventions for smoking cessation. Cochrane Database Syst Rev

;(1):CD000009.

ACS Great American Smokeout -- Promotion Guide, Nov. 16, 1989.

American Cancer Society. Kicking Butts: Quit Smoking and Take Charge

of Personal Health. Atlanta, GA. American Cancer Society, 2003

Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette:

A controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol

;14:767-90.

1992 EPA Report, Respiratory Health Effects of Passive Smoking.




DOI: http://dx.doi.org/10.22377/ajp.v2i4.205

Refbacks

  • There are currently no refbacks.